Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Wuxi Biologics
Research and Development in Biotechnology (except Nanobiotechnology)ChinaPNK: WXXWY
Last verified 7 months agowuxibiologics.com
Wuxi Biologics, a leading global player in the biotechnology sector, is headquartered in Wuxi, China. Founded in 2010, the company has rapidly established itself as a key provider of research and development services in biotechnology, excluding nanobiotechnology. With a strong presence in major operational regions across Asia, Europe, and North America, Wuxi Biologics focuses on offering comprehensive solutions for biologics development, including cell line development, process development, and analytical services.
The company is renowned for its innovative approach and state-of-the-art facilities, which enable it to deliver high-quality biologics at an accelerated pace. Wuxi Biologics has achieved significant milestones, including numerous partnerships with leading pharmaceutical companies, solidifying its position as a trusted partner in the biopharmaceutical industry. With a commitment to excellence and a robust portfolio of services, Wuxi Biologics continues to drive advancements in biotechnology.
60
DitchCarbon score
+34 vs industry average
Wuxi Biologics’s score of 60 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Wuxi Biologics?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very High
Research and Development in Biotechnology (except Nanobiotechnology) is among the most carbon-intensive industries
Industry performance
0.198
20182025
The Research and Development in Biotechnology (except Nanobiotechnology) industry has reduced its overall emissions by 19% since 2018
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Wuxi Biologics's reported carbon emissions
WuXi Biologics, a biotechnology research and development company headquartered in CN, reported its 2025 Scope 1 emissions at approximately 44.1 million kg CO2e, Scope 2 emissions at about 185.6 million kg CO2e, and Scope 3 emissions at approximately 86.8 million kg CO2e. This resulted in a total calculated emissions of about 316.5 million kg CO2e for the year.
Looking back, their 2024 emissions included approximately 38.3 million kg CO2e for Scope 1, 160.3 million kg CO2e for Scope 2, and 71.9 million kg CO2e for Scope 3, summing to a total of about 270.5 million kg CO2e. In 2023, Scope 1 emissions were around 32.7 million kg CO2e, Scope 2 emissions were roughly 149.2 million kg CO2e, and Scope 3 emissions reached approximately 65.5 million kg CO2e, for a total of about 247.4 million kg CO2e.
WuXi Biologics (Cayman) Inc. has set ambitious climate commitments validated by the Science Based Targets initiative (SBTi). The company aims to reach net-zero greenhouse gas emissions across its value chain by 2050. Near-term, it commits to reduce absolute Scope 1 and 2 GHG emissions by 58.8% by 2034 from a 2024 base year. Additionally, it targets a 63.8% reduction in Scope 3 GHG emissions covering purchased goods and services per kg of product produced within the same timeframe. Long-term, the company plans to reduce absolute Scope 1 and 2 GHG emissions by 90% by 2050 from a 2024 base year. It also commits to a 90% absolute reduction in Scope 3 GHG emissions covering purchased goods and services, capital goods, fuel and energy related activities, upstream transportation and distribution, waste generated in operations, and employee commuting by 2050.
Assessing Wuxi Biologics as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Wuxi Biologics and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Wuxi Biologics’s Climate Goals (2030 & 2050)
7 goals2050
90% reduction in Scope 2
WuXi Biologics (Cayman) Inc. commits to reduce absolute scope 1 and 2 GHG emissions 90% by 2050 from a 2024 base year.
Behind target90%
2050
90% reduction in scope 3 total
WuXi Biologics (Cayman) Inc. commits to reduce absolute scope 3 GHG emissions covering purchased goods and services, capital goods, fuel and…
Behind target90%
2050
90% reduction in Scope 1
WuXi Biologics (Cayman) Inc. commits to reduce absolute scope 1 and 2 GHG emissions 90% by 2050 from a 2024 base year.
Behind target90%
See all 7 climate goals
Sign up to see all goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
6 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
2034 targetSee details
Active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Wuxi Biologics7 months ago
60
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Wuxi Biologics’s sustainability data and climate commitments
In 2025, Wuxi Biologics reported total calculated emissions of approximately 316.5 million kg CO2e. The largest portion of these emissions comes from Scope 2, accounting for about 185.6 million kg CO2e. Scope 3 emissions were around 86.8 million kg CO2e, and Scope 1 emissions were approximately 44.1 million kg CO2e. This breakdown highlights the significant contribution of electricity consumption (Scope 2) to the company's overall carbon footprint within the biotechnology research and development sector.
Data year: 2025
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more